Ing Groep Nv Amarin Corp Plcuk Transaction History

Ing Groep Nv

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 08, 2019	SELL	$13.89 - $23.16 $8.86 Million - $14.8 Million	-638,000 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$16.27 - $20.51 $8.75 Million - $11 Million	538,000 Added 538.0%	638,000 $12.4 Million
Q1 2019 May 13, 2019	BUY	$12.61 - $22.33 $988,346 - $1.75 Million	78,378 Added 362.49%	100,000 $2.08 Million
Q4 2018 Feb 13, 2019	BUY	$12.41 - $22.98 $268,329 - $496,873	21,622 New	21,622 $294,000
Q3 2018 Nov 06, 2018	SELL	$2.45 - $16.27 $26,141 - $173,600	-10,670 Closed	0 $0
Q3 2017 Nov 08, 2017	BUY	$3.03 - $3.72 $32,330 - $39,692	10,670	10,670 $37,000

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $214M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Ing Groep Nv, based on Form 13F filings with the SEC.

Stay updated on Ing Groep Nv with notifications on news.